Michael Mina, MD, PhD

Chief Science Officer at eMed

Michael Mina, MD, PhD, began their work experience in 2016 as a Resident Physician in Clinical Pathology at Brigham and Women's Hospital / Harvard Medical School. Michael held this position until June 2019. From June 2019 to November 2021, they served as an Assistant Professor in Epidemiology, Immunology, and Clinical Pathology at Harvard University. Currently, since November 2021, they are the Chief Science Officer at eMed Digital Healthcare.

Michael Mina, MD, PhD has an extensive education background in various fields. Michael obtained their Bachelor's degree in Engineering and Global Health from Dartmouth College in 2006. Afterward, they pursued an MD/PhD program at Emory University from 2007 to 2016, specializing in Medicine and focusing on Infectious Disease Epidemiology and Immunology.

Following their MD/PhD, Mina completed a residency in Pathology at Harvard Medical School from 2016 to 2019. During this time, they also engaged in post-doctoral research at Harvard University, specializing in Genetics, Immunology, and Bioengineering.

In addition to their studies, Mina furthered their knowledge by undertaking a post-doc at Princeton University from 2013 to 2015, focusing on Mathematical Modeling and Infectious Disease Dynamics.

It is important to note that although the above information provides a comprehensive summary of Michael Mina's education history, no assumptions have been made beyond the given experience.

Links

Org chart

Timeline

  • Chief Science Officer

    November, 2021 - present

View in org chart